Rio Grande Urology

El Paso, Texas 79912

3 studies enrolling now · 7 studies all time

What they study most

Benign Prostatic Hyperplasia, NMIBC, Oligometastatic Prostate Cancer (OMPC), PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy, Prostate Cancer, Prostatic Neoplasm

Studies at this site

• An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. — Recruiting now
• A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC — Recruiting now
• Optilume™ BPH Catheter System in Men With Symptomatic BPH — Running, not enrolling
• A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC — Running, not enrolling
• SpaceIT Hydrogel System for Perirectal Spacing — Running, not enrolling
• ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer — Available (expanded access)
• Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer — Stopped early